JULIE TECENO: Open Payments
NPI 1154027910 · EATON RAPIDS, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$444 in 20 payments from 9 companies in 2025. Trend: 2023 $173 · 2024 $1,127 · 2025 $444
Food & beverage: $444
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 4 | $138 |
| Novo Nordisk Inc | 4 | $86 |
| ABBVIE INC. | 4 | $74 |
| AstraZeneca Pharmaceuticals LP | 2 | $49 |
| Amgen Inc. | 2 | $34 |
| GlaxoSmithKline, LLC. | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $15 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
Products named: Auvelity, Ozempic, VRAYLAR, AIRSUPRA, OTEZLA, Wegovy, UBRELVY, TRELEGY ELLIPTA.
Industry payments across MI — which companies pay providers there.
